Table 3.

Concomitant therapy of the thirty patients on anti-mycobacterial antibiotic therapy that returned for follow-up

	CR (n = 20)	PR + NR (n = 10)	P value
Concomitant biologic medication
Y, n (%)	3 (15)	3 (30)	0.37
N, n (%)	17 (85)	7 (70)
Concomitant steroid medication
Y, n (%)	13 (65)	3 (30)	0.12
N, n (%)	7 (35)	7 (70)
Concomitant IMD medication
Y, n (%)	12 (60)	1 (10)	0.02
N, n (%)	8 (40)	9 (90)
Concomitant 5-ASA medication
Y, n (%)	13 (65)	4 (40)	0.26
N, n (%)	7 (35)	6 (60)

CR: Complete resolution; PR: Partial resolution; NR: No resolution; Y: Yes; N: No; IMD: Immunomodulator; 5-ASA: 5-Aminosalicylate.